Nova Mentis Life Science Corp (OTCMKTS: NMLSF) has reviewed its 2021 pharmaceutical development milestones and highlighted its planned 2022 initiatives toward drug approvals and commercialization. NOVA...
Harborside Inc. (OTCMKTS: HBORF) has announced that Michael Dacks has resigned from its board of directors effective December 31, 2021. Harborside reconstituting its board of directors ...
Nova Mentis Life Science Corp (OTCMKTS: NMLSF) has received FDA and European Medicines Agency’s approval for its novel psilocybin drug Orphan Drug Application for fragile x...
Nova Mentis Life Science Corp (OTCMKTS: NMLSF) announced that the company had filed an application with the U.S. Food and Drug Administration (FDA). Through the application,...